Chodak: Let's Separate Counseling From Treatment Delivery
Should urologists who counsel patients about prostate cancer treatment be barred from providing that treatment? Dr. Gerald Chodak offers a provocative proposal to remove bias and improve patient care. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - December 11, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Topol: Cancer Mutation Screening 'Grossly Insufficient'
Dr. Eric Topol looks at where we stand on bridging the gap between basic science knowledge and clinical practice in the field of cancer genomics. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - November 25, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
IMRT Self-referrals Hurting Our Credibility
Some urologists are boosting their bottom lines by referring prostate cancer patients to their own radiation centers. Conflict of interest? Dr. Gerald Chodak discusses the issue. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - November 18, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Lifestyle Intervention: 5-Year Benefit in Prostate Cancer
A 3-month lifestyle intervention showed benefit at 5 years in men with low-risk prostate cancer, underscoring for Dr. Kathy Miller the importance of lifestyle in the lives of cancer patients. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - November 7, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
PC Screening: Good for the Individual, Bad for Society
A new study concludes that screening for prostate cancer"does more harm than good," yet individual patients should be told that they could benefit, says Dr. Gerald Chodak. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - October 28, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Prostate Cancer: Enough 'Me Too ’ Drugs
What we need are affordability endpoints, effective surrogate endpoints, and better information for our clinical colleagues, contend Drs. St é phane Oudard and Bertrand Tombal at ECC 2013. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - October 9, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Prostate Cancer: Enough 'Me Too’ Drugs
What we need are affordability endpoints, effective surrogate endpoints, and better information for our clinical colleagues, contend Drs. Stéphane Oudard and Bertrand Tombal at ECC 2013. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - October 9, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
